In addition to reducing the risk of other medical conditions, Polycystic Ovary Syndrome Treatment improves the health of the patient

Over the projection period, the high prevalence of polycystic ovary syndrome is anticipated to fuel market expansion for treatments for the condition. According to a study published in September 2019 titled "The Prevalence of Polycystic Ovary Syndrome in Adolescents: A Polycystic Ovary Syndrome Treatment  Review and Meta-analysis," the prevalence of polycystic ovarian syndrome in adolescents according to the Rotterdam criteria was 11.04%, according to the National Institute of Health criteria, it was 3.39%, and according to the Androgen Excess and Polycystic Ovary Syndrome Society, it was 8.03%.

Read More @ https://dailynewsmotion.weebly.com/blog/polycystic-ovary-syndrome-treatment-aims-to-reduce-the-risk-of-other-medical-conditions-and-also-improve-the-patients-health